Literature DB >> 7127906

Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.

D M Mitchell, P Fitzharris, R A Knight, G C Schild, M L Snaith.   

Abstract

Specific antibody responses to influenza viral antigens produced by cultured peripheral blood mononuclear leucocytes stimulated with influenza virus or pokeweed mitogen (PWM) have been measured in seven patients with systemic lupus erythematosus (SLE) before and at time intervals after influenza immunization. Cells from two patients stimulated with influenza virus in vitro produced high levels of specific antibody 7 days after immunization. Cells from a third patient produced small amounts of specific antibody at day 14. No antibody was produced by cells from the remaining four patients. Responses were of short duration and were not detectable 1 month after immunization. Specific anti-influenza antibody was induced by PWM only from cells of those patients who responded to virus antigen although absolute levels of antibody produced were not as high. In six patients serum haemagglutination inhibiting antibody to influenza virus was measured, and all six had a greater than four-fold increase. The disparity between in vitro antibody production by peripheral blood mononuclear leucocytes and changes in serum antibody suggests that in patients with systemic lupus erythematosus, in vitro functions of peripheral blood lymphocytes do not reflect the immune system as a whole.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127906      PMCID: PMC1536507     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

Review 2.  Lymphocytes and lymphocyte functions in systemic lupus erythematosus.

Authors:  E S Raveche; A D Steinberg
Journal:  Semin Hematol       Date:  1979-10       Impact factor: 3.851

3.  Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses.

Authors:  T Abe; M Homma
Journal:  Acta Rheumatol Scand       Date:  1971

4.  Influenzal vaccine response in systemic lupus erythematosus.

Authors:  R Brodman; R Gilfillan; D Glass; P H Schur
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

5.  Clinical and antibody responses after influenza immunization in systemic lupus erythematosus.

Authors:  J S Louie; K M Nies; K T Shoji; R C Fraback; C Abrass; W Border; J D Cherry; D Imagawa
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

6.  Specific in vitro antibody response to influenza virus by human blood lymphocytes.

Authors:  R E Callard
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

7.  Influenza immunization in systemic lupus eruthematosus. A double-blind trial.

Authors:  G W Williams; A D Steinberg; J L Reinertsen; L W Klassen; J L Decker; R Dolin
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

8.  Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.

Authors:  J Baum; M Ziff
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  Influenza vaccination of patients with systemic lupus erythematosus.

Authors:  S C Ristow; R G Douglas; J J Condemi
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

10.  Kinetics of specific in vitro antibody production following influenza immunization.

Authors:  D M Mitchell; P Fitzharris; R A Knight; G C Schild
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

View more
  3 in total

Review 1.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

2.  Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.

Authors:  M K Hari Kumar; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

3.  Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M E Devey; K Bleasdale; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.